Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa

BACKGROUND: We assessed the safety and immunogenicity of the RTS,S/AS01 malaria vaccine in a subset of children identified as HIV-infected during a large phase III randomized controlled trial conducted in seven sub-Saharan African countries. METHODS: Infants 6–12 weeks and children 5–17 months old w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Vaccine
Autori principali: Otieno, Lucas, Mendoza, Yolanda Guerra, Adjei, Samuel, Agbenyega, Tsiri, Agnandji, Selidji Todagbe, Aide, Pedro, Akoo, Pauline, Ansong, Daniel, Asante, Kwaku Poku, Berkley, James A, Gesase, Samwel, Hamel, Mary J., Hoffman, Irving, Kaali, Seyram, Kamthunzi, Portia, Kariuki, Simon, Kremsner, Peter, Lanaspa, Miguel, Lell, Bertrand, Lievens, Marc, Lusingu, John, Malabeja, Anangisye, Masoud, Nahya Salim, Mtoro, Ali Takadir, Njuguna, Patricia, Ofori-Anyinam, Opokua, Otieno, Godfrey Allan, Otieno, Walter, Owusu-Agyei, Seth, Schuerman, Lode, Sorgho, Hermann, Tanner, Marcel, Tinto, Halidou, Valea, Innocent, Vandoolaeghe, Pascale, Sacarlal, Jahit, Oneko, Martina
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2020
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7613311/
https://ncbi.nlm.nih.gov/pubmed/31708182
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2019.10.077
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi